Results 51 to 60 of about 15,396 (182)

Predicting optimal impact interventions in the post‐HPV vaccination world

International Journal of Cancer, Volume 158, Issue 9, Page 2262-2271, 1 May 2026.
Abstract Prophylactic vaccination is a powerful tool that changes exposure to infections and associated morbidity of preventable diseases. We discuss the impact of pneumococci and human papillomavirus (HPV) vaccination on the population biology of the two micro‐organisms and related public health effects.
Matti Lehtinen, Marc Lipsitch, Ville N. Pimenoff, Karin Sundström, Johannes Berkhof, Iacopo Baussano, Simopekka Vänskä, Joakim Dillner   +7 more
wiley   +1 more source

Invasive Pneumococcal Disease in Refugee Children, Germany

Emerging Infectious Diseases, 2018
Refugee children in Germany are not routinely given a pneumococcal conjugate vaccine. Cases of invasive pneumococcal disease (IPD) in 21 refugee children were compared with those in 405 Germany-born children for 3 pneumococcal seasons.
Stephanie Perniciaro, Matthias Imöhl, Mark van der Linden   +2 more
doaj   +1 more source

Protein conjugate pneumococcal vaccines.

BMJ (Clinical research ed.), 2002
BMJ
Spoulou, V., Gilks, C. F., Ioannidis, J. P.   +2 more
openaire   +2 more sources

Navigating Life With Inflammatory Bowel Disease: Challenges, Opportunities, and Support Strategies—A Scoping Review

JCC Plus, Volume 1, Issue 3, May 2026.
ABSTRACT Background Crohn’s disease and ulcerative colitis are chronic and increasingly prevalent conditions that significantly impact patients’ physical, psychological, and social well‐being. Although primarily affecting the gastrointestinal tract, IBD presents complex challenges that extend beyond physical symptoms, influencing multiple domains of ...
Ala I. Sharara, Zakaria El Kouzi, Amar Zaidan, Fayrouz Hachicho, Mohamad Ali Ibrahim, Nathalie Jbeily, Rita Francis, Sara Cooper, David Epstein   +8 more
wiley   +1 more source

Vaccination Coverage Against Coronavirus Disease 2019 (COVID‐19) in Brazil's Indigenous Population

Journal of Medical Virology, Volume 98, Issue 5, May 2026.
ABSTRACT Indigenous populations in Brazil were prioritized for coronavirus disease 2019 (COVID‐19) vaccination due to their increased vulnerability. The aim of the study was to describe COVID‐19 vaccination coverage among Indigenous population across Brazilian regions and Special Indigenous Health Districts (DSEIs; acronym for Distritos Sanitários ...
Nathália Mariana Santos Sansone, Patrícia Teixeira Costa, Lucas Silva Mello, Luiz Felipe Azevedo Marques, Vinícius Santiago dos Santos, Fernando Augusto Lima Marson   +5 more
wiley   +1 more source

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?

Vaccines, 2019
Since the introduction of the 13-valent pneumococcal conjugate vaccine, a number of studies have demonstrated the limited efficacy of the pneumococcal serotype 3 component of this vaccine. Evidence from seven countries (Denmark, France, Greece, Portugal,
Ezra Linley, Abigail Bell, Jenna F. Gritzfeld, Ray Borrow   +3 more
doaj   +1 more source

Trajectories and Risk Factors of Poor Physical and Mental Health Among Cancer Survivors Before, During, and After the COVID‐19 Pandemic

Psycho-Oncology, Volume 35, Issue 5, May 2026.
ABSTRACT Background The COVID‐19 pandemic severely disrupted healthcare and socioeconomic systems linked to worse health outcomes. However, its association with health‐related quality of life (HRQoL) among cancer survivors remains less well defined. Aim To evaluate pandemic‐related changes in HRQoL among cancer survivors. Methods Cancer survivors aged ≥
Qaidar Alizai, Areesh Mevawalla, Meher Angez, Rida Ejaz, Abdulaziz Elemosho, Sebastian Ekenze, Kizuki Yuza, Rabia Bega, Timothy M. Pawlik   +8 more
wiley   +1 more source

International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impactResearch in context

EBioMedicine, 2019
Background: Pneumococcal conjugate vaccines have reduced the incidence of invasive pneumococcal disease, caused by vaccine serotypes, but non-vaccine-serotypes remain a concern.
Rebecca A. Gladstone, Stephanie W. Lo, John A. Lees, Nicholas J. Croucher, Andries J. van Tonder, Jukka Corander, Andrew J. Page, Pekka Marttinen, Leon J. Bentley, Theresa J. Ochoa, Pak Leung Ho, Mignon du Plessis, Jennifer E. Cornick, Brenda Kwambana-Adams, Rachel Benisty, Susan A. Nzenze, Shabir A. Madhi, Paulina A. Hawkins, Dean B. Everett, Martin Antonio, Ron Dagan, Keith P. Klugman, Anne von Gottberg, Lesley McGee, Robert F. Breiman, Stephen D. Bentley   +25 more
doaj   +1 more source

Age at First RSV Hospitalisation and the Risk of Subsequent Bacterial Pneumonia

Acta Paediatrica, Volume 115, Issue 6, Page 1298-1300, June 2026.
Samuel Videholm, Karin Strandell, Maria Björmsjö, Andreas Tornevi, Sven Arne Silfverdal   +4 more
wiley   +1 more source

Pneumococcal conjugate vaccine--a health priority.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2008
Pneumonia is a major cause of childhood mortality and morbidity. Streptococcus pneumoniae is the most important bacterial pathogen causing pneumonia in children. The HIV epidemic has increased the burden and severity of childhood pneumococcal pneumonia and invasive disease fortyfold.
Zar, Heather J, Madhi, Shabir A
openaire   +3 more sources